Robert Ruffolo, PhD

Board Member

Robert currently serves as a Board Director on a number of clinical stage biotech companies. He is also the President of Ruffolo Consulting LLC, a pharmaceutical consulting company that he established in 2008. Previously, Robert served as the President of Research & Development and corporate Senior Vice President of Wyeth Pharmaceuticals (acquired by Pfizer in 2009) from 2000 to 2008. Prior to joining Wyeth, Robert was a Senior Vice President in Research & Development at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) for 17 years. Before joining SmithKline Beecham, Robert spent 6 years at Lilly Research Laboratories where he was Chairman of the Cardiovascular Research Committee. During his long career in the pharmaceutical industry, Robert oversaw the discovery and development of multiple marketed products. Robert holds a B.S. degree in Pharmacy, and a Ph.D. degree in Pharmacology, both from The Ohio State University.